Table 1.
Longitudinal evolution of blood values pre- and post-RT
| Timepoint | Management onset (3rd and 2nd pre-RT days) | 1st pre-RT day | 24 h post-RT | 2nd day | 3rd day | 4th day | 5th day | 8th day | |
|---|---|---|---|---|---|---|---|---|---|
| Hospital area | CIPA | CIPA | CIPA | ICU | ICU | ICU | ICU | ICU | CIPA |
| Hemoglobin g/dL (13.5–17.5) | 13.6 | NR | 13.8 | 13.2 | 13.2 | 13.1 | 13.3 | NR | 14.4 |
| Leucocytes/mm3 (4500–11,000) | 4240 | NR | 9190 | 5880 | 5730 | 5290 | 6010 | NR | 5430 |
| Bands (0–400) | 0 | NR | 0 | 0 | 0 | 0 | 0 | NR | 108 |
| Lymphocytes (1300–3500) | 920 | NR | 2417 | 1181.9 | 1048 | 820 | 1220 | NR | 1303 |
| Segmented (1400–6600) | NR | NR | NR | NR | NR | NR | NR | NR | NR |
| Platelets/mm3 (150,000–475,000) | 141,000 | NR | 167,000 | 230,000 | 276,000 | 319,000 | 351,000 | NR | 390,000 |
| D‑Dimer mg/L (0.0–0.5) | 0.45 | NR | 0.46 | NR | 1.33 | 1.32 | 1.13 | NR | 0.55 |
| GPT U/L (0.0–41.0) | 61 | NR | 130 | 124 | 117 | NR | NR | NR | 70 |
| AST U/L (0.0–40.0) | 65 | NR | 150 | 99 | 75 | NR | NR | NR | 33 |
| CRP mg/dL (0.0–0.5) | 14.99 | NR | 26.37 | 12.5 | 4.25 | 1.86 | 0.82 | NR | 0.24 |
| Procalcitonin ng/mL (0.0–0.5) | 0.15 | NR | 0.39 | NR | 0.16 | NR | NR | NR | NR |
| Troponin T ng/dL (0.0–0.05) | 0.01 | NR | 0.009 | NR | 0.006 | NR | 0.006 | NR | 0.007 |
| LDH U/L (135.0–225.0) | 393 | NR | 526 | 510 | 429 | 354 | 347 | NR | 260 |
| Ferritin ng/mL (20.0–250.0) | 1817 | NR | 925 | NR | 2418 | 1231.6 | 1034 | NR | 871.2 |
| IL‑6 pg/mL (0–7) | 107.1 | NR | 151.1 | NR | 1544 | 1117 | NR | NR | 243.3 |
CRP C-reactive protein, NR not registered, CIPA COVID in-patient area, RT Radiotherapy, ICU Intensive-care unit, GPT glutamate-pyruvate transaminase, AST aspartate aminotransferase, LDH Lactate dehydrogenase, IL-6 Interleukin 6